Chemours

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Chemours and other ETFs, options, and stocks.

About CC

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductors and consumer electronics, and general industrial.

CEO

Denise M. Dignam

CEODenise M. Dignam

Employees

5,700

Employees5,700

Headquarters

Wilmington, Delaware

HeadquartersWilmington, Delaware

Founded

2014

Founded2014

Employees

5,700

Employees5,700

CC Key Statistics

Market cap

2.30B

Market cap2.30B

Price-Earnings ratio

-5.33

Price-Earnings ratio-5.33

Dividend yield

2.05%

Dividend yield2.05%

Average volume

2.90M

Average volume2.90M

High today

$16.50

High today$16.50

Low today

$14.57

Low today$14.57

Open price

$16.01

Open price$16.01

Volume

10.41M

Volume10.41M

52 Week high

$28.67

52 Week high$28.67

52 Week low

$10.44

52 Week low$10.44

Stock Snapshot

The current Chemours(CC) stock price is $14.75, with a market capitalization of 2.3B. The stock trades at a price-to-earnings (P/E) ratio of -5.33 and offers a dividend yield of 2.05%.

During the trading session on 2026-08-06, Chemours(CC) shares reached a daily high of $16.50 and a low of $14.57. At a current price of $14.75, the stock is +1.2% higher than the low and still -10.6% under the high.

Trading volume for Chemours(CC) stock has reached 10.41M, versus its average volume of 2.9M.

The stock's 52-week range extends from a low of $10.44 to a high of $28.67.

CC News

Nasdaq 9h

Why Chemours Plunged on Wednesday

Key Points Chemours disappointed investors with a slight revenue decline in Q2. However, there were some one-off factors that limited revenue in the second qu...

The Motley Fool 10h

Why Chemours Plunged on Wednesday - The Motley Fool

...

TipRanks 14h

Chemours: Cyclical Trough Nearing, Margin Strength Supports Buy Rating with Unchanged $26 Price Target

Analyst John McNulty from BMO Capital maintained a Buy rating on Chemours Company and keeping the price target at $26.00. Unlock powerful investing tools with...

Analyst ratings

55%

of 11 ratings

Buy

54.5%

Hold

36.4%

Sell

9.1%

More CC News

TipRanks 1d

Chemours reports Q2 adjusted EPS 42c, consensus 42c

Reports Q2 revenue $1.6B, consensus $1.66B. “Our second quarter results reflect disciplined execution across our portfolio, with Adjusted EBITDA near the high e...

Simply Wall St 5d

Is Chemours Undervalued Or Are Legal Risks Already Priced In?

Chemours (CC) has drawn fresh attention after recent trading, with the stock closing at $16.61 on 29 July 2026. Investors are weighing this move against the com...

People also own

Based on the portfolios of people who own CC. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.